249 related articles for article (PubMed ID: 28630121)
1. A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy.
Kong Z; Qin P; Xiao S; Zhou H; Li H; Yang R; Liu X; Luo J; Li Z; Ji G; Cui Z; Bai Y; Wu Y; Shao L; Peng J; Ma J; Hou M
Blood; 2017 Aug; 130(9):1097-1103. PubMed ID: 28630121
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
Liu X; Bai Y; Wang T; Song Y; Sun F; Xia R; Zhu F; Ma J; Lu Q; Ye X; Zhan X; Li L; Guo X; Cheng S; Li Y; Guo Z; Chen Y; Qian S; Qin L; Zhang Q; Cao S; Yang R
Platelets; 2023 Dec; 34(1):2157806. PubMed ID: 36597010
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study.
Lin J; Wang TF; Huang MJ; Huang HB; Chen PF; Zhou Y; Dai WC; Zhou L; Feng XS; Wang HL
BMC Pregnancy Childbirth; 2023 Nov; 23(1):820. PubMed ID: 38012579
[TBL] [Abstract][Full Text] [Related]
4. Application of recombinant human thrombopoietin in pregnant women with immune thrombocytopenia: a single-center experience of four patients and literature review.
Yu J; Miao P; Qian S
J Int Med Res; 2023 Aug; 51(8):3000605231187950. PubMed ID: 37548331
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
Wang X; Bi H; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Wei Y; Li Y; Yin L; Mu H; Du Y; Zhou Z
Platelets; 2023 Dec; 34(1):2271568. PubMed ID: 37941414
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human thrombopoietin on immune thrombocytopenia in pregnancy in a murine model.
Liu Y; Wang R; Han P; Zhao Y; Li G; Li G; Nie M; Wang L; Chen J; Liu X; Hou M
Int Immunopharmacol; 2019 Feb; 67():287-293. PubMed ID: 30572253
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
Zheng J; Ma JY; Su Y; Yang J; Zhang RD; Zhou X; Wu RH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of recombinant human thrombopoietin in adult patients with primary immune thrombocytopenia during the perioperative period].
Sun HP; Hu Q; You JH; Chen QS; Wang J; Li JM; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):191-194. PubMed ID: 30929384
[No Abstract] [Full Text] [Related]
9. [Clinical Analysis of Recombinant Human Thrombopoietin for Treatment of 46 Adult Patients with Newly Diagnosed Primary Immune Thrombocytopenia].
Wang M; Liu YF; Sun H; Xie XS; Ma J; Gan SL; Dong YJ; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):531-5. PubMed ID: 27151024
[TBL] [Abstract][Full Text] [Related]
10. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
Zhao YQ; Wang QY; Zhai M; Xu J; Chen XQ; Liu WL; Zhang M; Song SJ; Wang JM; Meng FY; Shan YD
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
[TBL] [Abstract][Full Text] [Related]
11. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
12. [A clinical comparative study on treatment of severe newly diagnosed immune thrombocytopenia by recombinant human thrombopoietin combined with glucocorticoid].
Gu SY; Zhuang JL; Zou SH; Li F; Wang ZM; Cheng YF; Wang WG; Cheng ZX; Yuan L; Cheng LY; Wei Z
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):883-6. PubMed ID: 24171964
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of treatment with recombinant human thrombopoietin combined with large doses of dexamethasone in primary immune thrombocytopenia].
Sun M; Wang X; Jiang M; Bao X; Wang L; Liu Y; Wang X; Guo X
Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):202-5. PubMed ID: 26926372
[TBL] [Abstract][Full Text] [Related]
15. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
Chen M; Li L; Xia Q; Chen X; Liao Z; Wang C; Shen B; Zhou M; Zhang Q; Zhang Y; Qian L; Yuan X; Wang Z; Xue C; An X; Liu B; Gu K; Hou M; Wang X; Wang W; Li E; Zhong J; Cheng J; Shu Y; Yang N; Wang H; Yang R; Liu T; Deng T; Ma F; Liao W; Qiu W; Chen Y; Chen X; Zhang M; Xu R; Li X; Feng J; Ba Y; Shi Y
Cancer; 2024 Apr; 130(S8):1524-1538. PubMed ID: 38515388
[TBL] [Abstract][Full Text] [Related]
16. A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP.
Zhou H; Xu M; Qin P; Zhang HY; Yuan CL; Zhao HG; Cui ZG; Meng YS; Wang L; Zhou F; Wang X; Li DQ; Bi KH; Zhu CS; Guo CS; Chu XX; Wu QC; Liu XG; Dong XY; Li J; Peng J; Hou M
Blood; 2015 Mar; 125(10):1541-7. PubMed ID: 25575541
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of rhTPO in the treatment of pediatric primary immune thrombocytopenia].
Huang Y; Liu X; Xue F; Chen Y; Liu W; Fu R; Zhang L; Yang R
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):511-4. PubMed ID: 26134019
[TBL] [Abstract][Full Text] [Related]
18. Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.
Rosa María RN; Laura RL; Ángeles PB; Laura LB
Platelets; 2020; 31(3):403-406. PubMed ID: 31116059
[TBL] [Abstract][Full Text] [Related]
19. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
20. [The Treatment of Newly Diagnosed Primary Immune Thrombocytopenia by Recombinant Human Thrombopoietin Combined with Glucocorticoid].
Yuan J; Li LY; Wang ZZ; Liu XJ; Yang L; Luo JM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):832-835. PubMed ID: 35680813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
